Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
5 million on hand, 12.6 remaining at aspire - thats 17.6 million, more than enough for the next year of operations. Yep, good position to be in while negotiating for a Brilacidin deal.
Time to blow this 2.10 lid off! Does the recent new money understand the significance of Monday mornings?
I don't know enough about the inner workings, but what makes you say people are selling? Because the OTC reports a sell? Because the IHub trades page shows sells? If I try to buy 20k shares near the ask, but the Market Maker fills the order near the bid, then it is reported as a sell even though that transaction was a buy. So even a large exchange of shares accomplished in two sizable trades could give the impression that two sizable sells had occured. Why do this? Who knows? I'm not saying that this is the 'selling', but it is one possibility. Conspiracy theory: Big Pharma wants the price to stay depressed to reduce Leo's nogotiating position and so provides the illusion of large block selling with a little kickback to the Market Maker who puts on the show. Haha - I don't actually believe in that BS.
Noretreat - Can't say I ponder that very much - I know how my money balances with my risk strategy. The account managers at aspire also know how their management desires their accounts to be risked and it probably does involve selling to achieve the right balance. Everyone else who is selling for lack of discipline or personal risk understanding coordinated with CTIX's amazing potential - pure idiots, and unfortunately idiots are everywhere, they even invest where I invest, it's just too bad, haha.
Candlesticks are nice, but the buy rating was initiated when Leo explained via spoken and written word that Acute Bacterial Skin and Skin Structure Infection cure rates were increased beyond that of today's common ABSSSI drugs due to the 2 single-day-dose arms and the one 3-day-dose arm of Brilacidin in our recent trial. And then this buy rating was confirmed when Kevetrin jumped to 350 mg/m^2 and the IND for Brilacidin-OM was submitted.
I'll take a positive halt for the holidays!
Didn't Leo state in the presentation that the medical staff had implemented some pre-treatments to deal with some grade 2 events in earlier cohorts. Since that implementation, they have seen nothing above grade 1. This gave the review board confidence in allowing a typical dose escalation when no grade 2 events occur.
I wonder how long it will be until the trial is halted under recommendation from the review committee for immediate advancement into phase II/III?
Wow - B is a winner! K is a winner! We are winners!!!
Slide 10: B-OM IND "submitted September ____, 2014." So I think we find out, yes - IND is submitted.
Do people not see the blanks and TBD's in the slides??? Do we really believe that Leo did not submit a final late copy that corrects these and adds anything else significant?
Regarding Brilacidin's half-life: if I am remembering correctly, B has an advantageous ability to maintain a film layer adhesion to biological surfaces, thus making it an interesting option for ophthalmic uses as one would not need an over-frequent drip dose to the eye. It was brought up at the same time this insight was highlighted that perhaps orthopedic implants ranging from screws to joint replacements might benefit from a B-layering prior to installation. However, the body's ability to remove B from the bloodstream is sufficient enough to consider the drug in the shorter half-life category as it pertains to intravenous application. Someone correct me if I remembered this wrong.
I'll take a PB&K sandwich please!
Hehe, I live for speculation - I speculate that by the time any share transfer becomes tradable, it won't matter one bit. B P and K will be in overdrive along with our uplisted share price.
And don't forget about class B holdings, transfering common shares... pff.
Who do you think has been making these big buys the last week and ongoing? Maybe Menon has been solving this problem...
I think that gets into semantics - the company, the president of the company, etc. The arrangement between the president of the company and the company allowed use of term 'company' regarding Kevetrin. However, the semantics would become very important to the legal staff of any pharma company in discussions with Cellceutix.
What I have not seen mentioned yet is the importance of the final statement regarding the patent - it has now been transfered to CTIX. We don't know how long litigation has been ongoing with the two private parties and no doubt it was not appropriate to discuss litigation about a patent not owned by CTIX. Well, now CTIX retains the value of the molecule they are spending resources on prooving - this is HUGE. Only now can big pharma discuss making arrangements with CTIX as the patent owner. This is my interpretation of this great news - litigation over, CTIX can finally have K for real. I thank Menon for keeping this a private matter and not exposing us shareholders to the unknown liability regarding the patent.
He has beat you until 3.30 CTIX? Haha - what a joke! 3.30 CTIX is nothing! - Too bad his (Cramer's) ego hides the forest, we're gonna do-si-do through the trees right up to $100 per share before he mentions Cellceutix, just watch - you can call me anything you like, just don't call me late for CTIX!!! Haha
What happens to our market cap if we actually have an active revenue stream by years end?
Do I remember correctly that a correspondence occurred that stated we would be receiving an update on all platforms in August? Not much time left, mid-week-sneak-PR-attack approaching?
If it was from all insiders, then yes. However, only one individual is selling, and it's not a large sum of money - new house? son/daughter going to college? whatever?
Unless everyone unloads, it means nothing in my opinion. And most opinions from professionals state that it is insider buying that means something - not the selling.
I'll take 0.10+ per day till R&R - thank you!
A few more months and the wider market will perceive CTIX in a much different light. I'm ready for the next 6x - did it begin yesterday???
You've come to the right place! Taking some of your recent CTSO gains and applying here was genius in my opinion. CTIX has many multiples of potential over CTSO. Although I also keep some funds over there, I have about 20X invested here. Welcome and enjoy your new CTIX holdings!
Fall/winter 2012 was epic. I was buying early in the .30's - so double that triple! No doubt Fall/winter 2014 is going to be epic all over again. And, we both know that CTIX has been a 100% strong buy for months (long term anyways) - let's hope the short term'ers buy in big next week, duplicate our research, and turn into long term'ers. Welp, the clock is about to strike beer:30, cheers!
Since my prior valuation in January of 2013 (below), revenue multiples by sector data has been updated: Price/Sales of Biotech is now at 10.27 and Cellceutix has added significantly to their pipeline.
Brilacidin, Kevetrin, Prurisol - lets keep it at $20 Billion to be conservative . Outstanding shares really haven't taken a huge hit due to the brilliance of our management - I'll assume 170M in a few years.
pps=10.27*$20B/170M = $1208.24
Yep, CTIX is going to need to forward split a couple times.
Holy revenue cow!
It's looking like a new high is possible tomorrow... http://stockcharts.com/h-sc/ui?s=CTSO&p=D&b=5&g=0&id=p12648599896
Yep, now the numbers should make sense to everyone. georgejjl - we're not as far off as you lead people to believe, things are going to get very interesting come next Kevetrin trial... for all of us longs for sure.
Yes - maybe it takes several people to post the same info.
(my post an hour ago: #64784)
If we assume that 200[mg kg^-1] mouse dose is also the magic dose for humans (big assumption), this 200 mouse dose is equal to a 16.67[mg/kg] human dose.
https://ncifrederick.cancer.gov/Lasp/Acuc/Frederick/Media/Documents/ACUC42.pdf
At 215[mg m^-2], we are effectively at 5.81[mg kg^-1]. Even if this became MTD, the capable dose does not end there. Analysis of the PK/PD data will inform a new dose schedule for future studies. For example, the body is shown to process the dose and allow a full dose to be administered every 2 days. Rather than 5.81[mg kg^-1] once per week, a simple increase to three doses per week puts us at 17.43[mg kg^-1] per 'dose' and we are then at an 'equivalent 209[mg kg^-1] mouse dose'. Efficacy!!! (given our first assumption above)
I think we're in a great position right now, even with all of the assumptions we make. Things are looking great for this Phase I.
This is looking nice! http://stockcharts.com/h-sc/ui?s=CTSO&p=D&b=5&g=0&id=p77503928348
Is it Monday yet? Damn CTIX - ruining my weekends, hehe
Some strong closes approaching our quarterly report are quite welcome!
Is the OG crew beginning to re-convene upon CTIX...? Oh baby!
BTW - I maintain a pretty heavy tasty beer regimen myself - hope the Guinness also treats me well! ...and the speyside... congrats on a triumphant return.
Time to get back in. CT to the SO and to the IX.
$0.75 price target. This is what happens when sales begin to accelerate - buy ratings
https://merriman.bluematrix.com/sellside/EmailDocViewer?encrypt=10499d54-28da-40e2-9698-15286646a8b3&mime=pdf&co=Merriman&id=capitalmarkets@merrimanco.com&source=mail
1.72?! Feels like I haven't seen that for weeks. Is it beginning???
Prurisol Patent - Huge. eom
All this action above 0.25 I hope no one was foolish enough to sell around a half million shares in the .22-.23 range and then boast about it! Hahaha hahaha ahh ha ha ha